As this happened, Argus reiterated its Sanofi ADR [SNY] rating to a Buy in a research note published on July 26, 2024; the price target was $60. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who began to cover the stock in late January with a ‘”an Equal-weight”‘ rating. JP Morgan revised its rating on December 05, 2023. It rated SNY as “a Neutral” which previously was an “an Overweight”.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Price Performance Review of SNY
On Tuesday, Sanofi ADR [NASDAQ:SNY] saw its stock fall -0.64% to $54.57. Over the last five days, the stock has lost -0.51%. Sanofi ADR shares have risen nearly 9.73% since the year began. Nevertheless, the stocks have risen 0.07% over the past one year. While a 52-week high of $58.97 was reached on 09/04/24, a 52-week low of $42.63 was recorded on 04/18/24. SMA at 50 days reached $55.84, while 200 days put it at $50.66.
Levels Of Support And Resistance For SNY Stock
The 24-hour chart illustrates a support level at 53.96, which if violated will result in even more drops to 53.36. On the upside, there is a resistance level at 55.05. A further resistance level may holdings at 55.54. The Relative Strength Index (RSI) on the 14-day chart is 37.83, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.96, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 82.32%. Stochastics %K at 12.44% indicates the stock is a buying.
How much short interest is there in Sanofi ADR?
A steep rise in short interest was recorded in Sanofi ADR stocks on 2024-09-30, dropping by -1.99 million shares to a total of 9.14 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 11.12 million shares. There was a decline of -21.75%, which implies that there is a negative sentiment for the stock.
